Federal health officials have pared back the number of shots recommended for children. The states, led by Democrats, say the changes were not based on science.
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
The FDA agreed to review Moderna’s experimental mRNA influenza vaccine after Moderna resubmitted its application with modifications.
Researchers summarize key insights from the world’s first comprehensive investigation into how a pandemic started.
Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.
In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.
The Chosun Ilbo on MSN
14.2M COVID-19 vaccines administered despite foreign substance reports
Foreign substances such as mold, hair, and silicon dioxide (silica) were found in COVID-19 vaccines, potentially introduced ...
A 2023 law championed by Republicans requires the CDC have a director confirmed by the Senate. For months, though, it’s had ...
Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.
Just last week, the agency rejected Moderna’s initial application, citing flaws in the company’s research design.
Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results